DE60044584D1 - Protease from lucilia sericata und deren verwendung zur wundheilung - Google Patents

Protease from lucilia sericata und deren verwendung zur wundheilung

Info

Publication number
DE60044584D1
DE60044584D1 DE60044584T DE60044584T DE60044584D1 DE 60044584 D1 DE60044584 D1 DE 60044584D1 DE 60044584 T DE60044584 T DE 60044584T DE 60044584 T DE60044584 T DE 60044584T DE 60044584 D1 DE60044584 D1 DE 60044584D1
Authority
DE
Germany
Prior art keywords
amc
lucilia sericata
proteolytic activity
activity against
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044584T
Other languages
English (en)
Inventor
David Idris Pritchard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of DE60044584D1 publication Critical patent/DE60044584D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60044584T 1999-10-22 2000-10-20 Protease from lucilia sericata und deren verwendung zur wundheilung Expired - Lifetime DE60044584D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9925005.2A GB9925005D0 (en) 1999-10-22 1999-10-22 The treatment of wounds
PCT/GB2000/004034 WO2001031033A2 (en) 1999-10-22 2000-10-20 Protease from lucila sericata and its use in treatment of wounds

Publications (1)

Publication Number Publication Date
DE60044584D1 true DE60044584D1 (de) 2010-08-05

Family

ID=10863184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044584T Expired - Lifetime DE60044584D1 (de) 1999-10-22 2000-10-20 Protease from lucilia sericata und deren verwendung zur wundheilung

Country Status (7)

Country Link
US (2) US7144721B1 (de)
EP (1) EP1222285B1 (de)
AT (1) ATE471985T1 (de)
AU (1) AU7934500A (de)
DE (1) DE60044584D1 (de)
GB (1) GB9925005D0 (de)
WO (1) WO2001031033A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29924318U1 (de) * 1999-01-14 2002-09-19 Fleischmann Wilhelm Verbandsmaterial
US20080108551A1 (en) * 2006-07-06 2008-05-08 The Secretary Of State For Defence Treatment of wounds
DE10138303A1 (de) * 2001-08-10 2003-03-06 Aventis Pharma Gmbh Verwendung von Enzymisolaten aus Fliegenlarven zur Wundbehandlung
GB0127618D0 (en) * 2001-11-17 2002-01-09 Univ Nottingham "Composition and method for treatment of wounds"
GB0205593D0 (en) * 2002-03-09 2002-04-24 Univ Nottingham Treatment of surfaces populated by bacteria
DE10342104A1 (de) * 2003-09-10 2005-06-09 Fleischmann, Wilhelm, Dr.med. Verfahren zur Herstellung eines Mittels zur Wundbehandlung und nach diesem Verfahren hergestelltes Mittel
DE102005061246A1 (de) * 2005-12-20 2007-06-28 Alpha-Biocare Gmbh Präparate mit niedermolekularen Substanzen aus Dipteren zur Behandlung von Wunden
GB0607495D0 (en) * 2006-04-13 2006-05-24 Secr Defence Larval enzymes
EP2027148A2 (de) * 2006-05-31 2009-02-25 The Secretary of State for Defence DSTL Chymotrypsin aus larven von lucilia sericata und dessen verwendung zur wundbehandlung
GB0610697D0 (en) * 2006-05-31 2006-07-12 Secr Defence Larval enzyme
GB0700946D0 (en) * 2007-01-18 2007-02-28 Uws Ventures Ltd Antimicrobial composition and a method of controlling contamination and infection using said composition
EP2226382A1 (de) * 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease zur Wundbehandlung und Hautpflege
US10513696B2 (en) 2016-05-24 2019-12-24 Hamzeh Alipour Lucilia sericata collagenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007907A1 (en) * 1986-06-17 1987-12-30 Celltech Limited Process for the production of a protein
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5688768A (en) 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5892014A (en) 1996-10-30 1999-04-06 The Regents Of The University Of California DNA encoding a protease-activated receptor 3
WO1999043809A2 (en) 1998-02-27 1999-09-02 The Regents Of The University Of California Protease-activated receptor 4 and uses thereof

Also Published As

Publication number Publication date
GB9925005D0 (en) 1999-12-22
ATE471985T1 (de) 2010-07-15
US20070066538A1 (en) 2007-03-22
WO2001031033A2 (en) 2001-05-03
EP1222285B1 (de) 2010-06-23
US7144721B1 (en) 2006-12-05
WO2001031033A3 (en) 2001-09-20
EP1222285A2 (de) 2002-07-17
AU7934500A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
DE60044584D1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
NZ335981A (en) Ketobenzamides as calpain inhibitors
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
DE60027894D1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
CA2322502A1 (en) Protease inhibitors in absorbent articles
DE69939481D1 (de) Methode zur behandlung von diabetes die einen ap2-inhibitor und dazugehörige kombinationen verwendet
ATE277943T1 (de) Trypsininhibitoren
EP0832100A4 (de) Neuartige metalloprotease-inhibitoren, diese enthaltende pharmazeutische zusammensetzungen und anwendungsverfahren
HK1073438A1 (en) Furin inhibitors for use in the treatment of fibrosis and scarring
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
DE69519602T2 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
DE60018591D1 (de) Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE60123833D1 (de) Entwurf und verwendung von verbesserten zink-chelatbildenden peptiden zur regulation von matrix-metalloproteinasen
AU5986498A (en) Use of aminothiazoles for treating wounds and skin
JP2005518355A5 (de)
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
GB9626472D0 (en) New use of comt inhibitors
WO2007075853A3 (en) Protease compositions for the treatment of damaged tissue
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE360438T1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
DK1096951T3 (da) Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen